Drugs / CKD-357
last change Jun 2018 re-read 2 minutes ago

CKD-357

Investigated by
Chong Kun Dang Pharmaceutical

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03671941 May → Jun 2018 acute coronary syndrome Chong Kun Dang Pharmaceutical Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CKD-357 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03671941
Route Oral “single oral administration” NCT03671941